Paul S. Mishkin

We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing

We secured a decision from the DC Circuit reversing the SEC’s refusal to allow listing and trading of Grayscale Bitcoin Trust

We represent Syngenta in cases involving “crop inputs” and “loyalty rebate programs”

We achieved the denial of class certification in a claim involving retail foreign exchange investors

We secured NatWest's dismissal from numerous antitrust litigations alleging collusion in financial markets

The court dismissed all claims involving alleged manipulation of Mexican government bond prices

We successfully obtained dismissals of multiple claims

Davis Polk successfully represented the New York Stock Exchange LLC (“NYSE”) before the Securities and Exchange Commission (the “SEC” or “Commission”) in connection with NYSE’s proposed…

On September 4, 2020, Davis Polk filed a motion with the Securities and Exchange Commission (the “SEC” or “Commission”) on behalf of the New York Stock Exchange LLC (“NYSE”) to lift an…

On July 17, 2020, Davis Polk secured a complete dismissal on behalf of its client, AstraZeneca, in an Anti-Terrorism Act (“ATA”) lawsuit asserted against several pharmaceutical and medical…